Responsibilities of a Principal Investigator in Clinical Trials: What you Must Do to Ensure Trial Compliance
Madhavi Diwanji
60 Min
Product Id: 701868
Discussion on role and responsibilities of clinical trial investigator and the legal and regulatory requirements to follow for Good Clinical Practices (GCP)
Presenting the real GCP handbook: Build solid knowledge of GCP by learning the rules exactly as they appear in the official text
Leonidas Lambrinidis
78 Min
Product Id: 701888
Get a complete understanding of GCP through a comprehensive analysis of GCP official text - NOTE FOR GUIDANCE ON GOOD CLINICAL PRACTICE, CPMP/ICH/135/95, July 2002.
Principal Investigator responsibility in Research Involving Human Subjects: The International Conference on Harmonization (ICH) view
Charles H Pierce
90 Min
Product Id: 701077
This webinar will provide invaluable assistance to investigators and their staff in the regulatory / legal responsibilities and also the ethical considerations in pharmaceutical product (Drug or device) research involving human subjects.
Clinical Trials Process: Study Sponsor's and Investigator's Responsibilities
Elizabeth Bergan
Product Id: 701095
FDA Regulations and Good Clinical Practice Guidelines will be discussed with an emphasis on data integrity and the protection of study subject’s welfare/rights. This course will provide an overview of the Clinical Trial Process. It will discuss in detail the responsibilities of the Sponsor (company or institution managing the trial) and Investigators conducting a clinical trial.
Data and Safety Monitoring in Clinical Research Involving Human Subjects - When and How
Charles H Pierce
90 Min
Product Id: 700924
This webinar will provide invaluable assistance to investigators and their staff in the regulatory / legal responsibilities and also the ethical considerations in pharmaceutical product (Drug or device) research involving human subjects. All Clinical Research protocols have a prominent safety monitoring plan as part of the overall research plan / protocol. This "plan" is to ensure the safety of participating subjects and to ensure the validity and integrity of the data.
